DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dabigatran
Dabigatran
Dabigatran, Rivaroxaban, and Warfarin in the Oldest Adults With
DOACS COMPARISON and Faqs
Atrial Fibrillation
Laboratory Monitoring of Direct Oral Anticoagulants (Doacs)
Anticoagulant Pradaxa (Dabigatran Etexilate Mesylate) Savaysa (Edoxaban) Xarelto 2.5Mg (Rivaroxaban) Effective 01/01/2021
Estonian Statistics on Medicines 2016 1/41
Center for Drug Evaluation and Research Application
Periprocedural Management of Patients on Dabigatran Etexilate
PRADAXA Safely and Effectively
Estonian Statistics on Medicines 2013 1/44
PDF Download
Non-Interventional (Ni) Study Protocol
Cleveland Clinic Anticoagulation Management Program (C-Camp)
PRADAXA Safely and Effectively
Prescribing Information
PRADAXA (Dabigatran Etexilate Mesylate)
A Randomised Study of Dabigatran in Elective Percutaneous Coronary
Study Protocol
Top View
Combining Antiplatelets and Anticoagulants Example
Scientific Abstracts Thursday, 15 June 2017
Risk Factors for Bleeding Events with Enoxaparin, Dabigatran And
Rivaroxaban: a Fully-Subsidised Oral Anticoagulant
(Doacs) APIXABAN/DABIGATRAN/EDOXABAN/RIVAROXABAN
Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays
Guidance on Safe Switching of Warfarin to DOAC
Prescriptions of Direct Oral Anticoagulants in Patients Admitted
Bericht ATC-Code B01: Antithrombotische Mittel
Anticoagulants and Osteoporosis
Direct Oral Anticoagulants: from Randomized Clinical Trials to Real-World Clinical Practice
MEDICATION GUIDE PRADAXA (Pra Dax A) (Dabigatran Etexilate Mesylate) Capsules
Management of Dental Patients Taking Anticoagulants Or Antiplatelets
Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)
Guidelines for Management of Bleeding with Dabigatran Or Rivaroxaban: for Possible Use in Local Management Protocols
Clinical Trial Protocol Doc
Direct-Acting Oral Anticoagulant Use at Extremes of Body Weight
Report on the Deliberation Results December 1, 2010 Evaluation And
Dabigatran, Rivaroxaban, Edoxaban and Apixaban for AF
Successful Thrombolysis with Recombinant Tissue
Package Leaflet: Information for the Patient Pradaxa® 150 Mg Hard
Dabigatran Or Rivaroxaban Versus Other Anticoagulants For
What Is Dabigatran (Pradaxa)?
Queensland Health Guideline: Managing Patients on Dabigatran
Dabigatran Handout – UC Davis 2013
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
Switching to and from Various Anticoagulants
Parenteral Anticoagulation in Patients with Cancer Who Have No Therapeutic Or Prophylactic Indication for Anticoagulation (Review)
Direct Oral Anticoagulants (Doacs) Guide
Guidelines for ATC Classification and DDD Assignment 2021
Pradaxa, INN-Dabigatran Etexilate
761025Orig1s000
Successful Thrombolytic Therapy with Recombinant Tissue Plasminogen
Guidelines for ATC Classification and DDD Assignment 2013
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: a Systematic Review of the Literature and Analysis of Vigibase
Dabigatran (Pradaxa)
Dabigatran (Pradaxa)
Rivaroxaban (Xarelto), and Apixaban (Eliquis) September 2013 VHA Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives
Peri-Procedure Management of Anticoagulants
Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE
Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus
Anticoagulation in Acute Ischemic Stroke: a Systematic Search
Clinical Trial Protocol Doc